Stephen P. Squinto, EVP, Chief Global Operations Officer at ALEXION PHARMACEUTICALS INC (ALXN), sold 5,910 shares at $188.36 ($1.1M) on 2014-10-27, disclosed to the SEC on 2014-10-28.
Scheduled sale ($1.1M) by EVP, Chief Global Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $188.36 | 3,841 | $723K | 64.9% |
| 2 | $189.00 | 2,069 | $391K | 35.1% |
| Total | $188.58 avg | 5,910 | $1.1M | 100% |
| Filing → |
| SWTX | BUY | 2019-09-19 | $5.0M | — | Filing → |
| ALXN | SELL | 2014-10-07 | $1.7M | — | Filing → |
| ALXN | SELL | 2014-09-26 | $12K | — | Filing → |